Abstract | OBJECTIVES: METHODS: The study population consisted of 972 Caucasian subjects with T2DM of more than 10 years' duration: 161 patients with MI and 811 patients with no history of coronary artery disease. Polymorphisms in thioredoxin reductase 2 (TXNRD2) gene, rs1548357, rs4485648, and rs5748469, were studied. RESULTS: Individuals carrying CC+CT genotypes of rs1548357 TXNRD2 polymorphism had lower prevalence of MI compared with TT genotype group (41.6% vs 52.8%, OR=0.589, 95% CI=0.368-0.942, P=0.027). CONCLUSIONS: The TXNRD2 rs 1548357 polymorphism might be a genetic risk factor for MI in subjects with T2DM of Slovenian origin.
|
Authors | Stojan Kariž, Sara Mankoč, Daniel Petrovič |
Journal | Diabetes research and clinical practice
(Diabetes Res Clin Pract)
Vol. 108
Issue 2
Pg. 323-8
(May 2015)
ISSN: 1872-8227 [Electronic] Ireland |
PMID | 25703281
(Publication Type: Journal Article)
|
Copyright | Copyright © 2015 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- TXNRD2 protein, human
- Thioredoxin Reductase 2
|
Topics |
- Aged
- Diabetes Mellitus, Type 2
(complications, genetics)
- Diabetic Angiopathies
(epidemiology, genetics)
- Female
- Genetic Association Studies
- Genetic Predisposition to Disease
- Genotype
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(complications, genetics)
- Polymorphism, Single Nucleotide
- Slovenia
(epidemiology)
- Thioredoxin Reductase 2
(genetics)
- White People
(genetics)
|